Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?

J. Musil, V. Vondra (Prague, Czech Republic)

Source: Annual Congress 2001 - Monitoring acute lung disease
Session: Monitoring acute lung disease
Session type: Thematic Poster Session
Number: 1651
Disease area: Airway diseases, Respiratory critical care

Congress or journal article abstract

Abstract

The aim of prospective study was to find out the parameters, which can help us to predict the outcomes of treatment of severe COPD exacerbations in ICU.
Authors evaluated a group of 64 patients (50 without and 14 with mechanical ventilation /MV/). FEV1, PaO2, PaCO2, pH, serum concentration of theophylline, lactate, hematocrit were measured on admission and then every day during the hospitalization in ICU.
Patients without necessary MV had on admission significantly higher values of PaO2 (8,5 ±]1,6 kPa) than those with necessary MV (6,4±] 2,0, p< 0,01). They also had significantly lower values of PaCO2 (5,2 ±] 0,9 kPa) than ventilated persons (6,7 ±] 1,6 kPa, p< 0,01). After 24 hours of treatment in the group of non ventilated patients the FEV1% of predicted value significantly increased (24,8 ±] 13,9 on admission, 40,6 ±] 17,7, p< 0,01 after 24 hours). After 24 hours of treatment both subgroups differed in the values of PaO2 and PaCO2. The mean value of PaO2 in ventilated patients was 6,7 ±] 2,0 kPa, in the non ventilated ones 9,5 ±] 2,0 kPa (p <0,01). The mean value of PaCO2 in ventilated patients was 8,2 ±]2,0 kPa, in non- ventilated ones was 5,3±] 0,8 kPa (p< 0,01).
On the subgroup of ventilated patients differed from the subgroup of non ventilated one on admission, and after 24 hours they differed in the values of blood gases. Authors didn¢t find out any cut-off values of measured parameters, which allow to predict, which patient has to be ventilated.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Musil, V. Vondra (Prague, Czech Republic). Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?. Eur Respir J 2001; 16: Suppl. 31, 1651

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 55s
Year: 2005

The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Impact of anemia in patients admitted due to a chronic obstructive pulmonary disease (COPD) exacerbation.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009



The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011



Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011

The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 211s
Year: 2001

Calorie-intake in patients hospitalized for an acute COPD exacerbation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007



Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007




Does health status predict survival in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 203s
Year: 2002

Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Pulmonary rehabilitation and its effect on exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Reasons for hospitalisation patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 473s
Year: 2002

Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 241s
Year: 2003